Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Factor XIII A-subunit

Factor XIII-A subunit · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Factor XIII A-subunit, covering 2014-06-12 to 2014-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency [Phase 3]

See pricing